Physician profile
Alyssa Becker
NPI 1023187143
$5,718.73
in general payments reported to CMS, 2019-2025
32 companies · $993 in 2025
The $993 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.85 · 2020: $647 · 2021: $1,008 · 2022: $1,128 · 2023: $1,271 · 2024: $594 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,857.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,552.65 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $787.49 | 2021-2025 | Vraylar |
| Lilly USA, LLC | $685.85 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $583.87 | 2019-2025 | Evenity, Repatha, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $507.09 | 2021-2025 | Jardiance |
| Allergan, INC. | $149.79 | 2020 | |
| Daiichi Sankyo INC. | $146.67 | 2021-2025 | Injectafer |
| Phathom Pharmaceuticals, INC. | $137.06 | 2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.98 | 2022 | |
| Amarin Pharma, INC. | $122.45 | 2019-2022 | |
| Exact Sciences Corporation | $110.20 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $104.70 | 2022-2025 | Freestyle Libre 2, Eterna, Freestyle Libre 3 |
| Medtronic, INC. | $99.37 | 2022-2024 | Minimed 780g |
| Kowa Pharmaceuticals America, INC. | $97.03 | 2020-2023 | Seglentis, Livalo |
| Pfizer INC. | $74.90 | 2020-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $55.43 | 2022 | |
| Glaxosmithkline, LLC. | $45.34 | 2020-2025 | Shingrix |
| Astellas Pharma US INC | $41.11 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $40.87 | 2023-2025 | Spravato |
| Sanofi-Aventis U.S. LLC | $33.12 | 2021-2024 | |
| Dexcom, INC. | $32.28 | 2023 | Dexcom G6 Transmitter |
| Soleno Therapeutics, INC. | $30.42 | 2025 | Vykat Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $29.94 | 2021 | |
| Axsome Therapeutics, INC. | $17.05 | 2023 | Auvelity |
| Novartis Pharmaceuticals Corporation | $15.99 | 2019 | |
| Dermira, INC. | $15.00 | 2020 | |
| Althera Pharmaceuticals LLC | $14.18 | 2021 | |
| Amneal Pharmaceuticals LLC | $13.40 | 2021 | |
| Eisai INC. | $13.10 | 2024 | |
| Merck Sharp & Dohme LLC | $12.72 | 2021 | |
| Avion Pharmaceuticals | $12.38 | 2020 | |
| Medicure Pharma INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.